4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-290622
Director sold 18,000 shares at $3.65 ($65,614)
From the SEC's structured data for this filing
Trades in this filing
Ezekowitz Alan · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-26 | Sale : show line 1 in the form | −18,000 | $3.65 | $65,614 | 10,927 | D |
| Open-market sales · 18,000 sh · avg $3.65 · $65,614 | ||||||
Loading xslF345X06/ownership.xml…